Regenera Moléculas do Mar
PrivateLast Round
Grant
Feb 24, 2024
Total Funding Raised
$330,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Regenera Moléculas do Mar operates in Healthcare & Life Sciences and is based in Porto Alegre. Its latest recorded funding round was a Grant round in February 2024.
Regenera Moléculas do Mar is a biotechnology company that offers research and development solutions to various industries using Brazilian marine biodiversity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Sustainable Materials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenera Moléculas do Mar Comparables
Compare Regenera Moléculas do Mar with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apoena Biotech | 84% | |
| Biosortia Microbiomics | 78% | |
| Sirenas Marine Discovery | 76% |
For institutional investors. Book with your work email.
Regenera Moléculas do Mar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 24, 2024 | ||||
| Grant | Jan 24, 2024 | ||||
| Accelerator | Mar 1, 2017 |
For institutional investors. Book with your work email.
Regenera Moléculas do Mar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Conselho Nacional de Desenvolvimento Científico e Tecnológico | Grant |
| Serviço Nacional de Aprendizagem Industrial | Grant |
| Empresa Brasileira de Pesquisa e Inovação Industrial | Grant |
| Financiadora de Estudos e Projetos | Grant |
| Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul | Grant |
| InovAtiva Brasil | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 125% MoM, reaching 1.8K.
- May 15, 2026
Monthly visitors increased 34% MoM.
For institutional investors. Book with your work email.
Regenera Moléculas do Mar Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Regenera Moléculas do Mar's valuation, stock price, and market status.
Is Regenera Moléculas do Mar a public or private company?
Regenera Moléculas do Mar is a private company.
What is the current stock price of Regenera Moléculas do Mar?
Regenera Moléculas do Mar is a private company, so its shares have no public market price. Caplight tracks Regenera Moléculas do Mar's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Regenera Moléculas do Mar worth (valuation)?
Valuation information for Regenera Moléculas do Mar is not publicly available.
Can I buy Regenera Moléculas do Mar stock?
Regenera Moléculas do Mar shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Regenera Moléculas do Mar's last funding round?
Regenera Moléculas do Mar's most recent funding round was Grant on February 24, 2024.
Who are the main investors in Regenera Moléculas do Mar?
Key investors in Regenera Moléculas do Mar include Empresa Brasileira de Pesquisa e Inovação Industrial, Financiadora de Estudos e Projetos.
Will Regenera Moléculas do Mar IPO soon?
No public IPO plans have been announced for Regenera Moléculas do Mar.
How can I track Regenera Moléculas do Mar secondary market activity?
Caplight tracks bids, offers, and trades in Regenera Moléculas do Mar's shares on secondary markets.